Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update

被引:57
作者
Ciarallo, Anthony [1 ]
Rivera, Juan [2 ]
机构
[1] McGill Univ, Hlth Ctr, Dept Med Imaging, Div Nucl Med, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada
[2] McGill Univ, Hlth Ctr, Dept Med, Div Endocrinol & Metab, Montreal, PQ, Canada
关键词
differentiated thyroid cancer; DTC; I-131; radioactive iodine therapy; RAI; thyroid cancer; RADIOIODINE-REMNANT ABLATION; I-131; METAANALYSIS; PATIENT;
D O I
10.2214/AJR.19.22626
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of optimizing outcomes. This principle is being applied to radioactive iodine therapy. Consequently, thyroid cancer therapy protocols are evolving. The purpose of this article is to promote a modern approach to radioiodine therapy. CONCLUSION. This article highlights guidelines and position statements, summarizes the prognostication systems of thyroid cancer, and reviews which prescribed activities of I-131 are appropriate for each risk category.
引用
收藏
页码:285 / 291
页数:7
相关论文
共 30 条
[21]   Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association [J].
Tuttle, R. Michael ;
Ahuja, Sukhjeet ;
Avram, Anca M. ;
Bernet, Victor J. ;
Bourguet, Patrick ;
Daniels, Gilbert H. ;
Dillehay, Gary ;
Draganescu, Ciprian ;
Flux, Glenn ;
Fuehrer, Dagmar ;
Giovanella, Luca ;
Greenspan, Bennett ;
Luster, Markus ;
Muylle, Kristoff ;
Smit, Johannes W. A. ;
Van Nostrand, Douglas ;
Verburg, Frederik A. ;
Hegedus, Laszlo .
THYROID, 2019, 29 (04) :461-470
[22]   Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-Up [J].
Tuttle, R. Michael ;
Alzahrani, Ali S. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (09) :4087-4100
[23]   Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? [J].
Tuttle, R. Michael ;
Haugen, Bryan ;
Perrier, Nancy D. .
THYROID, 2017, 27 (06) :751-756
[24]  
Van Nostrand D., 2016, Thyroid cancer: a comprehensive guide to clinical management, P245
[25]   Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer [J].
Van Nostrand, Douglas .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2017, 46 (03) :783-+
[26]   Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer [J].
van Velsen, Evert F. S. ;
Stegenga, Merel T. ;
van Kemenade, Folkert J. ;
Kam, Boen L. R. ;
van Ginhoven, Tessa M. ;
Visser, W. Edward ;
Peeters, Robin P. .
THYROID, 2018, 28 (08) :976-981
[27]   I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence [J].
Yan Shengguang ;
Ji-Eun, Choi ;
He Lijuan .
MEDICAL SCIENCE MONITOR, 2016, 22 :2439-2450
[28]   Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database [J].
Yang, Fan ;
Zhong, Qi ;
Huang, Zhigang ;
Lian, Meng ;
Fang, Jugao .
FRONTIERS IN ENDOCRINOLOGY, 2019, 10
[29]   Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure [J].
Yeyin, Nami ;
Cavdar, Iffet ;
Uslu, Lebriz ;
Abuqbeitah, Mohammad ;
Demir, Mustafa .
NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (03) :283-287
[30]   Conventional Radioiodine Therapy for Differentiated Thyroid Cancer [J].
Ylli, Donna ;
Van Nostrand, Douglas ;
Wartofsky, Leonard .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) :181-+